ArticleJCO oncology practice2026

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

Megan Othus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.